Immunophotonics crunchbase
WitrynaImmunophotonics, Inc. 479 followers on LinkedIn. Interventional Immuno-Oncology Immunophotonics is a privately owned clinical stage biotech that has discovered a novel and simple approach to achieve patient-specific anticancer immunity. The company is currently developing its first asset, the immune-modulating proprietary carbohydrate … WitrynaCB Rank (Person) 549,025. Primary Job Title Co-Founder. Primary Organization. ImmunoPhotonics. Gender Male. Dr. Hode has worked in the photomedicine and …
Immunophotonics crunchbase
Did you know?
Witryna27 maj 2011 · ImmunoPhotonics raised $100123 on 2011-05-27 in Pre Seed Round. Unlock even more features with Crunchbase Pro WitrynaImmunoPhotonics raised $550000 on 2010-05-12 in Pre Seed Round. Start Free Trial
WitrynaOperating Status Active. Last Funding Type Post-IPO Debt. Legal Name Rockley Photonics Ltd. Stock Symbol NYSE:RKLY. Company Type For Profit. Contact Email [email protected]. Phone Number +1 626-304-9960. Rockley is developing a comprehensive range of photonic integrated circuits and associated … WitrynaIn response, Immunophotonics is developing IP-001, an immune-stimulating drug designed to induce potent antitumor immune activation when administered with …
Witryna18 mar 2024 · Co-Founder & Chief Information Officer & President, At Immunophotonics, Inc at AACR . Tomas Hode, Ph.D., who received his Ph.D. in 2005, is a co-founder of Immmunophotonics, and has more than 10 years experience in the medical laser device industry. Dr. Hode has been a board member of the Missouri … Witryna9 sie 2024 · ImmunoPhotonics. Crunchbase Website Twitter Facebook Linkedin. Minimally invasive therapeutic cancer vaccine for the treatment of metastatic solid tumors. EyePromise. Crunchbase Website Twitter Facebook Linkedin. EyePromise manufactures and sells zeaxanthin dietary supplements for those at risk of age …
WitrynaImmunophotonics is a privately owned clinical-stage biotech company that is pioneering the burgeoning field of Interventional Immuno-OncologyTM through the development of novel treatments for solid-tumor cancers. IP-001, the first asset from the company’s intellectual property platform, has the potential to transform a routine tumor ablation …
Witryna26 sty 2015 · ImmunoPhotonics raised $600000 on 2015-01-26 in Series A. Cultivation Capital Cultivation Capital is a venture capital firm managing funds focused on … greenbrier high school football scoreWitrynaImmunoPhotonics. Biotechnology. Health Care. Life Science. $21M: 06 Apr 2024: iSELECT FUND. Columbia, Missouri, United States: By posting comments on our website you confirm and acknowledge that: 1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the … greenbrier high school football rosterflower summerWitrynaImmunoPhotonics raised $50000 on 2013-05-14 in Grant. Start Free Trial . Chrome Extension flower summer plantsWitrynaImmunophotonics is a privately owned clinical stage biotech that has discovered a novel and simple approach to achieve patient-specific anticancer immunity. The … greenbrier high school football tnWitrynaImmunoPhotonics raised $1800000 on 2014-09-03 in Series A. Start Free Trial . Chrome Extension greenbrier high school libraryWitrynaFounded Date 1983. Operating Status Active. Last Funding Type Post-IPO Equity. Also Known As IPA. Stock Symbol NASDAQ:IPA. Company Type For Profit. Contact Email … greenbrier high school marching band